Forte Biosciences, Inc.

Healthcare

NASDAQ:FBRX · NASDAQ Capital Market

Market Cap $247.23M Beta 2.87 P/E (TTM) -41.3

$17.15 +0.92%

+$0.16 today

52W Low $9.10High $35.80

Vol 0.17M · Avg 0.30M

EPS (TTM) -$0.43Biotechnology

Management

Put operating results in leadership context

Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.

Return Metrics

ROE, ROIC & ROA over time

Management

Older years hidden. Sign in to unlock

ROE

-113.7%

avg -107.7%

ROIC

-113.9%

avg -64.6%

ROA

-83.8%

avg -59.6%

Analysis

ROA is currently the strongest return metric at -83.8% versus its period average of -59.6%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Management

Key executives, compensation & ownership

Management

Name	Title	Compensation	Tenure	Age	Shares Owned	Ownership %
Paul A. Wagner	Chief Executive Officer, President & Chairman	$1.41M	—	56	$84,428.00	0.61%
Antony A. Riley	Chief Financial Officer	$632,953.00	—	59	$42,116.00	0.30%
Barbara K. Finck	Acting Senior Medical Clinician & Director	$600,000.00	—	79	$31,000.00	0.22%
Christopher Roenfeldt	Chief Operating Officer	—	—	—	—	—

Insider Trading

SEC Form 4 transactions — last 12 months

Management

Buys

$254,832.78

Sells

$0.00

Net Sentiment

+$254,832.78

Net buying

Most Active

Riley Antony A

1 transactions

Date	Insider	Type	Shares	Price	Value
Dec 30, 2025	Riley Antony A Direct	Buy	9.7K	$26.33	$254,832.78

Analysis

Insiders reported 1 buys worth $254,832.78 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $254,832.78. Riley Antony A was the most active insider with 1 transactions.